J&J develops treatments for some of the most devastating disorders and complex medical challenges of our times, including cancer, hepatitis, HIV/AIDS, diabetes, arthritis, dementia, and mental disorders. We focus our research on five strategic pathological areas: oncology, neurosciences, infectious diseases and vaccines, immunology, and cardiovascular and metabolic disorders.
Dr. Paul J&J founded the company in 1953 with only one thing in mind: saving people’s lives thanks to the development of better medicines. In 1961, the company affiliated with the Johnson & Johnson Group, global market leader in healthcare products. The group has more than 265 operational companies in 60 countries today and more than 128,000 employees worldwide.
Quick facts about J&J in Baltic Countries:
- We employ around 40 people in Estonia, Latvia and Lithuania
- Our offices in Tallinn, Riga and Vilnius:
UAB “JOHNSON & JOHNSON” Eesti filiaal Lõõtsa str. 2 EE-11415 Tallinn, Estonia |
UAB “JOHNSON & JOHNSON” filiāle Latvijā Mukusalas str. 101 LV-1004 Riga, Latvia |
UAB “JOHNSON & JOHNSON” Konstitucijos av. 21C, Vilnius, QUADRUM business center north, 5th floor LT-08130 Lithuania Tel +370 5 278 6888 Fax +370 5 278 6889 |
- We are driven by the J&J Credo, which was founded in 1943 by Robert Wood
- Johnson Our Credo challenges us to put the needs and well-being of the people we serve first